The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf …
M Poiani, M Labopin, G Battipaglia… - American journal of …, 2021 - Wiley Online Library
Karyotypic analysis at time of diagnosis has an important value in determining initial
response to treatment, remission duration and overall survival (OS) in acute myeloid …
response to treatment, remission duration and overall survival (OS) in acute myeloid …
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: on behalf …
M Poiani, M Labopin, G Battipaglia, DW Beelen… - 2020 - lilloa.univ-lille.fr
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation
in patients with relapsed/refractory acute myeloid leukemia: on behalf of the acute leukemia …
in patients with relapsed/refractory acute myeloid leukemia: on behalf of the acute leukemia …
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf …
M Poiani, M Labopin, G Battipaglia… - American Journal …, 2020 - epub.ub.uni-muenchen.de
Karyotypic analysis at time of diagnosis has an important value in determining initial
response to treatment, remission duration and overall survival (OS) in acute myeloid …
response to treatment, remission duration and overall survival (OS) in acute myeloid …
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf …
M Poiani, M Labopin, G Battipaglia… - AMERICAN JOURNAL …, 2021 - iris.unina.it
Karyotypic analysis at time of diagnosis has an important value in determining initial
response to treatment, remission duration and overall survival (OS) in acute myeloid …
response to treatment, remission duration and overall survival (OS) in acute myeloid …
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf …
M Poiani, M Labopin, G Battipaglia… - American Journal of …, 2020 - europepmc.org
Karyotypic analysis at time of diagnosis has an important value in determining initial
response to treatment, remission duration and overall survival (OS) in acute myeloid …
response to treatment, remission duration and overall survival (OS) in acute myeloid …
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf …
M Poiani, M Labopin, G Battipaglia… - American journal of …, 2020 - folia.unifr.ch
English Karyotypic analysis at time of diagnosis has an important value in determining initial
response to treatment, remission duration and overall survival (OS) in acute myeloid …
response to treatment, remission duration and overall survival (OS) in acute myeloid …
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf …
M Poiani, M Labopin, G Battipaglia… - American journal …, 2021 - pubmed.ncbi.nlm.nih.gov
Karyotypic analysis at time of diagnosis has an important value in determining initial
response to treatment, remission duration and overall survival (OS) in acute myeloid …
response to treatment, remission duration and overall survival (OS) in acute myeloid …
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf …
M Poiani, M Labopin, G Battipaglia, DW Beelen… - American journal of …, 2020 - sonar.ch
English Karyotypic analysis at time of diagnosis has an important value in determining initial
response to treatment, remission duration and overall survival (OS) in acute myeloid …
response to treatment, remission duration and overall survival (OS) in acute myeloid …
[引用][C] The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On …
M Poiani, M Labopin, G Battipaglia… - American journal of …, 2021 - freidok.uni-freiburg.de
FreiDok plus - The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic
cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of …
cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of …